Article
ALK Is a Specific Diagnostic Marker for Inflammatory Myofibroblastic Tumor of the Uterus.
The American journal of surgical pathology - 1 Oct 2018
Mohammad Nissreen, Haimes Josh D, Mishkin Skyler, Kudlow Brian A, Leong May Ying, Chew Sung Hock, Koay Eleanor, Whitehouse Ann, Cope Nichola, Ali Rola H, Köbel Martin, Stewart Colin J R, McCluggage W Glenn, Lee Cheng-Han
Abstract excerpt
Inflammatory myofibroblastic tumor (IMT) is a myofibroblastic/fibroblastic neoplasm of intermediate malignant potential. It is frequently characterized by genetic fusion of ALK with a variety of partner genes, which results in the activated ALK signaling pathway that can be targeted with kinase inhibitors. IMTs can occur in the gynecologic tract, with the uterus (corpus and cervix) being the most frequent site....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
